Monthly Erenumab may induce Remission of Medication-Overuse Headache in Chronic Migraine Patients: Study Jacinthlyn Sylvia25 Sept 2024 8:15 PM ISTA new study by Stewart Tepper and team showed that monthly 140 mg erenumab injections in individuals with non-opioid chronic migraine and drug overuse...
Erenumab reduces rosacea-associated flushing and erythema symptoms: JAMA Jacinthlyn Sylvia2 May 2024 9:30 AM ISTA recent study published in the Journal of American Medical Association found promising results after investigating the use of erenumab which is a...
Erenumab: A Potential Breakthrough in Rosacea Management Medha Baranwal18 April 2024 9:00 AM ISTDenmark: A nonrandomized controlled trial showed the importance of the calcitonin gene-related peptide (CGRP) pathway in the pathophysiology of...
Promising Results for Erenumab in Treating Episodic Migraine, shows APPRAISE Trial Dr.Niharika Harsha B27 March 2024 7:30 PM ISTIn a novel trial, researchers have found that erenumab may be a more effective and tolerable option for patients with episodic migraine who have not...
Migraine patients treated with anti-CGRP receptor antibodies at risk of developing high BP Aditi8 Dec 2022 10:00 AM ISTNetherlands: A study published in Neurology has concluded that migraine patients are at risk of developing high blood pressure when treated with...
Erenumab effective in patients with migraine: JAMA Dr. Shravani Dali27 Dec 2021 9:00 AM ISTErenumab treatment in patients with migraine with and without a history of aura is effective, according to a new study published in the JAMA ...
Erenumab Improves Functional Outcomes of Episodic Migraine: LIBERTY Trial MD Bureau17 May 2021 10:45 AM ISTErenumab is a fully human monoclonal antibody that inhibits the canonical calcitonin gene-related peptide (CGRP) receptor. A recent study suggests...
